BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11713302)

  • 1. A minimal Bcl-x promoter is activated by Brn-3a and repressed by p53.
    Sugars KL; Budhram-Mahadeo V; Packham G; Latchman DS
    Nucleic Acids Res; 2001 Nov; 29(22):4530-40. PubMed ID: 11713302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct promoter elements mediate the co-operative effect of Brn-3a and p53 on the p21 promoter and their antagonism on the Bax promoter.
    Perez-Sanchez C; Budhram-Mahadeo VS; Latchman DS
    Nucleic Acids Res; 2002 Nov; 30(22):4872-80. PubMed ID: 12433990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brn-3a transcription factor blocks p53-mediated activation of proapoptotic target genes Noxa and Bax in vitro and in vivo to determine cell fate.
    Hudson CD; Morris PJ; Latchman DS; Budhram-Mahadeo VS
    J Biol Chem; 2005 Mar; 280(12):11851-8. PubMed ID: 15598651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Brn-3a POU family transcription factor stimulates p53 gene expression in human and mouse tumour cells.
    Budhram-Mahadeo V; Morris P; Ndisang D; Irshad S; Lozano G; Pedley B; Latchman DS
    Neurosci Lett; 2002 Dec; 334(1):1-4. PubMed ID: 12431761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Brn-3a transcription factor inhibits the pro-apoptotic effect of p53 and enhances cell cycle arrest by differentially regulating the activity of the p53 target genes encoding Bax and p21(CIP1/Waf1).
    Budram-Mahadeo V; Morris PJ; Latchman DS
    Oncogene; 2002 Sep; 21(39):6123-31. PubMed ID: 12203124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factor.
    Budhram-Mahadeo V; Morris PJ; Smith MD; Midgley CA; Boxer LM; Latchman DS
    J Biol Chem; 1999 May; 274(21):15237-44. PubMed ID: 10329733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brn-3a, a neuronal transcription factor of the POU gene family: indications for its involvement in cancer and angiogenesis.
    Chiarugi V; Del Rosso M; Magnelli L
    Mol Biotechnol; 2002 Oct; 22(2):123-7. PubMed ID: 12405260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bcl-2 transcription from the proximal P2 promoter is activated in neuronal cells by the Brn-3a POU family transcription factor.
    Smith MD; Ensor EA; Coffin RS; Boxer LM; Latchman DS
    J Biol Chem; 1998 Jul; 273(27):16715-22. PubMed ID: 9642226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The N-terminal domain unique to the long form of the Brn-3a transcription factor is essential to protect neuronal cells from apoptosis and for the activation of Bbcl-2 gene expression.
    Smith MD; Dawson SJ; Boxer LM; Latchman DS
    Nucleic Acids Res; 1998 Sep; 26(18):4100-7. PubMed ID: 9722627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the iNOS gene promoter by Brn-3 POU family transcription factors is dependent upon the octamer motif in the promoter.
    Gay RD; Dawson SJ; Murphy WJ; Russell SW; Latchman DS
    Biochim Biophys Acta; 1998 Dec; 1443(3):315-22. PubMed ID: 9878805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional interaction between Brn-3a and Src-1 co-activates Brn-3a-mediated transactivation.
    Dennis JH; Budhram-Mahadeo V; Latchman DS
    Biochem Biophys Res Commun; 2002 Jun; 294(2):487-95. PubMed ID: 12051737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective transcription of p53 target genes by zinc finger-p53 DNA binding domain chimeras.
    Falke D; Fisher MH; Juliano RL
    Biochim Biophys Acta; 2004 Nov; 1681(1):15-27. PubMed ID: 15566940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of NGFI-A (Egr-1) gene expression by the POU domain transcription factor Brn-3a.
    Smith MD; Ensor EA; Stohl L; Wagner JA; Latchman DS
    Brain Res Mol Brain Res; 1999 Dec; 74(1-2):117-25. PubMed ID: 10640682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brn-3a activates the expression of Bcl-x(L) and promotes neuronal survival in vivo as well as in vitro.
    Smith MD; Melton LA; Ensor EA; Packham G; Anderson P; Kinloch RA; Latchman DS
    Mol Cell Neurosci; 2001 Mar; 17(3):460-70. PubMed ID: 11273642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EWS differentially activates transcription of the Brn-3a long and short isoform mRNAs from distinct promoters.
    Thomas GR; Faulkes DJ; Gascoyne D; Latchman DS
    Biochem Biophys Res Commun; 2004 Jun; 318(4):1045-51. PubMed ID: 15147979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coordinate induction of the three neurofilament genes by the Brn-3a transcription factor.
    Smith MD; Morris PJ; Dawson SJ; Schwartz ML; Schlaepfer WW; Latchman DS
    J Biol Chem; 1997 Aug; 272(34):21325-33. PubMed ID: 9261145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The functionally antagonistic POU family transcription factors Brn-3a and Brn-3b show opposite changes in expression during the growth arrest and differentiation of human neuroblastoma cells.
    Smith MD; Latchman DS
    Int J Cancer; 1996 Sep; 67(5):653-60. PubMed ID: 8782654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression of the POU factor Brn-3a is regulated by two different promoters.
    Frass B; Vassen L; Möröy T
    Biochim Biophys Acta; 2002 Dec; 1579(2-3):207-13. PubMed ID: 12427558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-mobility group A1 proteins regulate p53-mediated transcription of Bcl-2 gene.
    Esposito F; Tornincasa M; Chieffi P; De Martino I; Pierantoni GM; Fusco A
    Cancer Res; 2010 Jul; 70(13):5379-88. PubMed ID: 20530667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Brn-3a transcription factor plays a key role in regulating the growth of cervical cancer cells in vivo.
    Ndisang D; Budhram-Mahadeo V; Pedley B; Latchman DS
    Oncogene; 2001 Aug; 20(35):4899-903. PubMed ID: 11521202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.